These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
205 related articles for article (PubMed ID: 1398909)
1. Effects of alginase on the natural history and antibiotic therapy of experimental endocarditis caused by mucoid Pseudomonas aeruginosa. Bayer AS; Park S; Ramos MC; Nast CC; Eftekhar F; Schiller NL Infect Immun; 1992 Oct; 60(10):3979-85. PubMed ID: 1398909 [TBL] [Abstract][Full Text] [Related]
2. Functional role of mucoid exopolysaccharide (alginate) in antibiotic-induced and polymorphonuclear leukocyte-mediated killing of Pseudomonas aeruginosa. Bayer AS; Speert DP; Park S; Tu J; Witt M; Nast CC; Norman DC Infect Immun; 1991 Jan; 59(1):302-8. PubMed ID: 1898898 [TBL] [Abstract][Full Text] [Related]
3. Oxygen-dependent up-regulation of mucoid exopolysaccharide (alginate) production in Pseudomonas aeruginosa. Bayer AS; Eftekhar F; Tu J; Nast CC; Speert DP Infect Immun; 1990 May; 58(5):1344-9. PubMed ID: 2139011 [TBL] [Abstract][Full Text] [Related]
4. Adaptive resistance of Pseudomonas aeruginosa induced by aminoglycosides and killing kinetics in a rabbit endocarditis model. Xiong YQ; Caillon J; Kergueris MF; Drugeon H; Baron D; Potel G; Bayer AS Antimicrob Agents Chemother; 1997 Apr; 41(4):823-6. PubMed ID: 9087497 [TBL] [Abstract][Full Text] [Related]
5. Alginase treatment of mucoid Pseudomonas aeruginosa enhances phagocytosis by human monocyte-derived macrophages. Eftekhar F; Speert DP Infect Immun; 1988 Nov; 56(11):2788-93. PubMed ID: 3139564 [TBL] [Abstract][Full Text] [Related]
6. Inhibition of adherence of mucoid Pseudomonas aeruginosa by alginase, specific monoclonal antibodies, and antibiotics. Mai GT; McCormack JG; Seow WK; Pier GB; Jackson LA; Thong YH Infect Immun; 1993 Oct; 61(10):4338-43. PubMed ID: 8406822 [TBL] [Abstract][Full Text] [Related]
7. Oxygen-dependent differences in exopolysaccharide production and aminoglycoside inhibitory-bactericidal interactions with Pseudomonas aeruginosa--implications for endocarditis. Bayer AS; O'Brien T; Norman DC; Nast CC J Antimicrob Chemother; 1989 Jan; 23(1):21-35. PubMed ID: 2501267 [TBL] [Abstract][Full Text] [Related]
8. Development of beta-lactam resistance and increased quinolone MICs during therapy of experimental Pseudomonas aeruginosa endocarditis. Bayer AS; Hirano L; Yih J Antimicrob Agents Chemother; 1988 Feb; 32(2):231-5. PubMed ID: 3129985 [TBL] [Abstract][Full Text] [Related]
9. Suppression of lymphocyte and neutrophil functions by Pseudomonas aeruginosa mucoid exopolysaccharide (alginate): reversal by physicochemical, alginase, and specific monoclonal antibody treatments. Mai GT; Seow WK; Pier GB; McCormack JG; Thong YH Infect Immun; 1993 Feb; 61(2):559-64. PubMed ID: 8423085 [TBL] [Abstract][Full Text] [Related]
10. Amikacin + ceftazidime therapy of experimental right-sided Pseudomonas aeruginosa endocarditis in rabbits. Bayer AS; Lam K; Norman D; Kim KS; Morrison JO Chemotherapy; 1985; 31(5):351-61. PubMed ID: 3931992 [TBL] [Abstract][Full Text] [Related]
11. Characterization of impermeability variants of Pseudomonas aeruginosa isolated during unsuccessful therapy of experimental endocarditis. Bayer AS; Norman DC; Kim KS Antimicrob Agents Chemother; 1987 Jan; 31(1):70-5. PubMed ID: 3105442 [TBL] [Abstract][Full Text] [Related]
12. Isolation and characterization of an alginase from mucoid strains of Pseudomonas aeruginosa. Linker A; Evans LR J Bacteriol; 1984 Sep; 159(3):958-64. PubMed ID: 6434516 [TBL] [Abstract][Full Text] [Related]
13. Inhibition of polymorphonuclear leukocyte chemotaxis by the mucoid exopolysaccharide of Pseudomonas aeruginosa. Stiver HG; Zachidniak K; Speert DP Clin Invest Med; 1988 Aug; 11(4):247-52. PubMed ID: 2971496 [TBL] [Abstract][Full Text] [Related]
14. Pathogenic effects of monocytopenia, granulocytopenia and dexamethasone on the course of experimental Pseudomonas aeruginosa endocarditis in rabbits. Bayer AS; Yih J; Chiu CY; Nast CC Chemotherapy; 1989; 35(4):278-88. PubMed ID: 2504546 [TBL] [Abstract][Full Text] [Related]
15. Biologic activities of antibodies to the neutral-polysaccharide component of the Pseudomonas aeruginosa lipopolysaccharide are blocked by O side chains and mucoid exopolysaccharide (alginate). Hatano K; Goldberg JB; Pier GB Infect Immun; 1995 Jan; 63(1):21-6. PubMed ID: 7528730 [TBL] [Abstract][Full Text] [Related]
16. Efficacy of amikacin and ceftazidime in experimental aortic valve endocarditis due to Pseudomonas aeruginosa. Bayer AS; Norman D; Kim KS Antimicrob Agents Chemother; 1985 Dec; 28(6):781-5. PubMed ID: 3909954 [TBL] [Abstract][Full Text] [Related]
17. Immunization with outer membrane proteins (OprF and OprI) and flagellin BÂ protects mice from pulmonary infection with mucoid and nonmucoid Pseudomonas aeruginosa. Hassan R; El-Naggar W; Abd El-Aziz AM; Shaaban M; Kenawy HI; Ali YM J Microbiol Immunol Infect; 2018 Jun; 51(3):312-320. PubMed ID: 28291719 [TBL] [Abstract][Full Text] [Related]
18. In vivo efficacy of azlocillin and amikacin versus ciprofloxacin with and without amikacin in experimental right-sided endocarditis due to Pseudomonas aeruginosa. Bayer AS; Kim KS Chemotherapy; 1986; 32(4):364-73. PubMed ID: 2942342 [TBL] [Abstract][Full Text] [Related]